Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial
- 31 October 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 383 (9915), 413-423
- https://doi.org/10.1016/s0140-6736(13)62037-1
Abstract
No abstract availableFunding Information
- Abbott Vascular
- Biotronik
- Medtronic
- Boston Scientific Corporation
This publication has 28 references indexed in Scilit:
- Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: 2-Year Follow-Up of the Randomized TWENTE TrialJournal of the American College of Cardiology, 2013
- Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary InterventionCell Metabolism, 2012
- A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World PatientsJournal of the American College of Cardiology, 2012
- Acute and 16‐month outcomes of a new stent: The first‐in‐man evaluation of the medtronic S9 (integrity) stentCatheterization and Cardiovascular Interventions, 2011
- PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenosesEuroIntervention, 2011
- Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries: The RESOLUTE US Clinical TrialJournal of the American College of Cardiology, 2011
- A Prospective, Randomized Evaluation of a Novel Everolimus-Eluting Coronary Stent: The PLATINUM (A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of up to Two De Novo Coronary Artery Lesions) TrialJournal of the American College of Cardiology, 2011
- Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary StentsNew England Journal of Medicine, 2010
- Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificityEuroIntervention, 2010
- Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopyEuroIntervention, 2009